Skip to Content
Biotechnology

Russia says it has a covid vaccine called “Sputnik-V”

Vladimir Putin claims a newly developed coronavirus countermeasure is a symbol of his country's scientific prowess.
Vladimir Putin
Wikimedia commons

Russia has cleared a vaccine against covid-19 for emergency use on health-care workers this fall.

Fast advance:  Russian president Vladimir Putin said during a meeting on Tuesday that the newly registered vaccine “has passed all the necessary tests” and that one of his daughters had received the inoculation.  

“She has taken part in the experiment,” Putin said, according to the Associated Press.

Vaccination program: The Russian vaccine was developed by the Gamaleya National Research Center for Epidemiology and Microbiology in Moscow. Although it has been tested on some volunteers, Russia has not finished the larger type of study needed to prove it is safe or protects recipients against infection by the coronavirus.

According to reports, doctors, nurses, and teachers will be given the shot first when enough supplies of the vaccine are ready in October, and it could reach the general public by January.

The Russian vaccine uses an adenovirus to deliver components of the pathogen that causes covid-19. The approach is similar to one being advanced by Oxford University and AstraZeneca, according to the New York Times,

National pride: Vaccines against covid-19 could be wielded as a tool of geopolitical power, with nations offering supplies to friends and allies. The Russian shot is named Sputnik-V, a clear allusion to the dramatic Soviet launch of the first space satellite in 1957, according to CNN.

“Americans were surprised when they heard Sputnik’s beeping. It’s the same with this vaccine. Russia will have got there first,” Kirill Dmitriev, head of the Russian Direct Investment Fund, said in June.  

There are close to 900,000 reported cases of coronavirus infection in Russia, the fourth-highest number in the world.

Risky race: The Russian vaccine claim could encourage the Trump administration to fast-track emergency approval of one of several vaccines being tested by the US program, Operation Warp Speed. Some scientists fear that the vaccine could become a pawn in American election politics and have cautioned against distributing an untested injection.

China, too: In June, China also approved a vaccine, made by CanSino Biologics, for use by its military. The country has offered experimental vaccines to officials at state enterprises in China.

Deep Dive

Biotechnology

How scientists want to make you young again

Research labs are pursuing technology to “reprogram” aging bodies back to youth.

Inside the billion-dollar meeting for the mega-rich who want to live forever

Hope, hype, and self-experimentation collided at an exclusive conference for ultra-rich investors who want to extend their lives past 100. I went along for the ride.

Human brain cells transplanted into baby rats’ brains grow and form connections

When lab-grown clumps of human neurons are transplanted into newborn rats, they grow with the animals. The research raises some tricky ethical questions.

The debate over whether aging is a disease rages on

In its latest catalogue of health conditions, the World Health Organization almost equated old age with disease. Then it backed off.

Stay connected

Illustration by Rose Wong

Get the latest updates from
MIT Technology Review

Discover special offers, top stories, upcoming events, and more.

Thank you for submitting your email!

Explore more newsletters

It looks like something went wrong.

We’re having trouble saving your preferences. Try refreshing this page and updating them one more time. If you continue to get this message, reach out to us at customer-service@technologyreview.com with a list of newsletters you’d like to receive.